Steven D Nathan, Ho Cheol Kim, Christopher S King, Shambhu Aryal, Christopher Thomas, Zein Kattih, Oksana A Shlobin, Vikramjit Khangoora, Abhimanyu Chandel
{"title":"Serial Pulmonary Hemodynamics in Patients with IPF Listed for Lung Transplant.","authors":"Steven D Nathan, Ho Cheol Kim, Christopher S King, Shambhu Aryal, Christopher Thomas, Zein Kattih, Oksana A Shlobin, Vikramjit Khangoora, Abhimanyu Chandel","doi":"10.1164/rccm.202411-2157OC","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Pulmonary hypertension (PH) commonly complicates idiopathic pulmonary fibrosis (IPF). However, the rate of change in pulmonary hemodynamics in IPF remains poorly defined.</p><p><strong>Objectives: </strong>To examine the rate of change in pulmonary hemodynamics among patients with IPF.</p><p><strong>Methods: </strong>The rate of change in mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) was examined in patients with IPF listed for lung transplantation. The 5th and 7th World Symposium on Pulmonary Hypertension definitions for precapillary PH were employed in this analysis.</p><p><strong>Measurements and main results: </strong>There were 496 patients with IPF that had at least two right heart catheterizations (RHCs) while listed for lung transplantation. The median time between repeated RHCs was 9 months (interquartile range [IQR]: 6-14). PH was present in 25.8% and 46.8% at the first RHC, while 42.9% and 64.3% had PH by the two definitions respectively, at the time of the final RHC. The median rate of change in the mPAP and PVR were 3.8 mmHg/year (IQR: -0.9-11.8) and 0.8 Wood Units/year (IQR: -0.2-2.4), respectively. The rate of PVR change was slower for those with established PH compared with those without PH. 28.6% of the patients had accelerated progression of their hemodynamics, arbitrarily defined as an increase in PVR of ≥ 2 Wood Units/year.</p><p><strong>Conclusions: </strong>PH associated with IPF tends to progress in an unpredictable fashion, with some patients demonstrating an accelerated phenotype. Among patients with RHC hemodynamics below the threshold for therapy, close vigilance is warranted with consideration for an early repeat RHC. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>","PeriodicalId":7664,"journal":{"name":"American journal of respiratory and critical care medicine","volume":" ","pages":""},"PeriodicalIF":19.3000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory and critical care medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1164/rccm.202411-2157OC","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Pulmonary hypertension (PH) commonly complicates idiopathic pulmonary fibrosis (IPF). However, the rate of change in pulmonary hemodynamics in IPF remains poorly defined.
Objectives: To examine the rate of change in pulmonary hemodynamics among patients with IPF.
Methods: The rate of change in mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) was examined in patients with IPF listed for lung transplantation. The 5th and 7th World Symposium on Pulmonary Hypertension definitions for precapillary PH were employed in this analysis.
Measurements and main results: There were 496 patients with IPF that had at least two right heart catheterizations (RHCs) while listed for lung transplantation. The median time between repeated RHCs was 9 months (interquartile range [IQR]: 6-14). PH was present in 25.8% and 46.8% at the first RHC, while 42.9% and 64.3% had PH by the two definitions respectively, at the time of the final RHC. The median rate of change in the mPAP and PVR were 3.8 mmHg/year (IQR: -0.9-11.8) and 0.8 Wood Units/year (IQR: -0.2-2.4), respectively. The rate of PVR change was slower for those with established PH compared with those without PH. 28.6% of the patients had accelerated progression of their hemodynamics, arbitrarily defined as an increase in PVR of ≥ 2 Wood Units/year.
Conclusions: PH associated with IPF tends to progress in an unpredictable fashion, with some patients demonstrating an accelerated phenotype. Among patients with RHC hemodynamics below the threshold for therapy, close vigilance is warranted with consideration for an early repeat RHC. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).
期刊介绍:
The American Journal of Respiratory and Critical Care Medicine focuses on human biology and disease, as well as animal studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients. Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish clinical trials and outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Critical Care Perspectives or Pulmonary Perspectives. These are generally focused on a more limited area and advance a concerted opinion about care for a specific process. Concise Clinical Reviews provide an evidence-based synthesis of the literature pertaining to topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. Images providing advances or unusual contributions to the field are published as Images in Pulmonary, Critical Care, Sleep Medicine and the Sciences.
A recent trend and future direction of the Journal has been to include debates of a topical nature on issues of importance in pulmonary and critical care medicine and to the membership of the American Thoracic Society. Other recent changes have included encompassing works from the field of critical care medicine and the extension of the editorial governing of journal policy to colleagues outside of the United States of America. The focus and direction of the Journal is to establish an international forum for state-of-the-art respiratory and critical care medicine.